Loss of the vitamin D receptor triggers senescence in chronic myeloid leukemia via DDIT4-mediated DNA damage
Journal of Molecular Cell Biology · 2024
DOI: 10.1093/jmcb/mjad066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2024. Verfasst von Yan Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Lab of Chemical Biology (MOE), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. Hauptthemen laut MEDLINE: DNA Damage, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Receptors, Calcitriol, Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Taishan Scholars Program, Multidisciplinary Research and Innovation Team of Young Scholars of Shandong University.
Abstract (Originalsprache)
Chronic myeloid leukemia (CML) is a hematopoietic malignancy driven by the fusion gene BCR::ABL1. Drug resistance to tyrosine kinase inhibitors (TKIs), due to BCR::ABL1 mutations and residual leukemia stem cells (LSCs), remains a major challenge in CML treatment. Here, we revealed the requirement of the vitamin D receptor (VDR) in the progression of CML. VDR was upregulated by BCR::ABL1 and highly expressed in CML cells. Interestingly, VDR knockdown inhibited the proliferation of CML cells driven by both BCR::ABL1 and TKI-resistant BCR::ABL1 mutations. Mechanistically, VDR transcriptionally regulated DDIT4 expression; reduced DDIT4 levels upon VDR knockdown triggered DNA damage and senescence via p53 signaling activation in CML cells. Furthermore, VDR deficiency not only suppressed tumor burden and progression in primary CML mice but also reduced the self-renewal capacity of CML-LSCs. Together, our study demonstrated that targeting VDR is a promising strategy to overcome TKI resistance and eradicate LSCs in CML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Lab of Chemical Biology (MOE), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
- Department of Pharmacology, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
- School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250012, China.
- Department of Hematology, Heze Municipal Hospital, Heze 274031, China.
ORCID-Profile: Zhiyuan Lu, Baobing Zhao
Förderung
- National Natural Science Foundation of China
- Taishan Scholars Program
- Multidisciplinary Research and Innovation Team of Young Scholars of Shandong University
- Natural Science Foundation of Shandong Province
- University of Ministry of Education of China
- State Key Laboratory of Microbial Technology
Zitieren
APA
Xu, Y., Qi, W., Zheng, C., Li, Y., Lu, Z., Guan, J., Lu, C., & Zhao, B. (2024). Loss of the vitamin D receptor triggers senescence in chronic myeloid leukemia via DDIT4-mediated DNA damage. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjad066
Vancouver
Xu Y, Qi W, Zheng C, Li Y, Lu Z, Guan J, et al. Loss of the vitamin D receptor triggers senescence in chronic myeloid leukemia via DDIT4-mediated DNA damage. Journal of Molecular Cell Biology. 2024. doi:10.1093/jmcb/mjad066
BibTeX
@article{Xu2024,
author = {Xu, Yan and Qi, Wentao and Zheng, Chengzu and Li, Yuan and Lu, Zhiyuan and Guan, Jianmin and Lu, Chunhua and Zhao, Baobing},
title = {Loss of the vitamin D receptor triggers senescence in chronic myeloid leukemia via DDIT4-mediated DNA damage},
journal = {Journal of Molecular Cell Biology},
year = {2024},
doi = {10.1093/jmcb/mjad066}
}
EUVIMED